Navigation Links
A scientific breakthrough on the control of the bad cholesterol
Date:11/24/2008

Montral, November 24, 2008 A study performed by the team of Dr. Nabil G. Seidah, Director of the Biochemical Neuroendocrinology Research Unit at the IRCM, shows for the very first time that the degradation by PCSK9 of the LDLR receptor, which is responsible for removing the bad cholesterol (LDL-cholesterol) from the bloodstream, may be inhibited by a third protein, annexin A2. This major discovery co-authored by Gatan Mayer, a postdoctoral fellow, Steve Poirier, a doctoral student, and Dr. Seidah was published on November 14 in the Journal of Biological Chemistry (JBC).

Genetic studies on humans have clearly shown that PCSK9 is a prime therapeutic target for the prevention and treatment of cardiovascular diseases. PCSK9 proprotein convertase promotes the degradation of the receptor responsible for eliminating LDL-cholesterol particles. Thus, the presence of PCSK9 leads to a surplus of bad cholesterol in the bloodstream and contributes to plaque formation, leading to blockage of blood vessels and arteries. This phenomenon is a major risk factor that can lead to cardiovascular diseases, such as heart attack, atherosclerosis and stroke. Mutations of human genes have demonstrated that a rise in PCSK9 activity results in a major increase in LDL-cholesterol and familial hypercholesterolemia. Conversely, in people with a non-functional mutation in the gene coding for PCSK9, a decrease in its activity brings down the LDL-cholesterol concentration levels in the bloodstream and diminishes by up to 88% the risks of developing cardiovascular diseases.

"By performing a series of biochemical experiments, we discovered that annexin A2 binds strongly to PCSK9 and inhibits its function," remarks Gatan Mayer, the article's first author. This discovery should pave the way toward the development of a new drug that would lower blood cholesterol to recommended levels. Currently, cholesterol lowering drugs known as "statins" are used by more than 25 m
'/>"/>

Contact: Nabil G. Seidah
seidahn@ircm.qc.ca
514-987-5609
Institut de recherches cliniques de Montreal
Source:Eurekalert

2

GOOD

Page: 1 2

Related biology news :

1. Barrow scientists solve 200-year-old scientific debate involving visual illusions
2. Scientific community called upon to resolve debate on net energy once and for all
3. Top scientific meeting urges coordinated response to economic and environmental crises
4. Loggerhead release to provide vital information to scientific community
5. NIAID scientists to speak on range of infectious disease topics at major scientific meeting
6. ETH Zurich-administered fund ends scientific anonymity
7. Gene therapy anti-cancer research featured in Scientific American
8. In scientific first, Einstein researchers correct decline in organ function associated with old age
9. The emerging scientific discipline of aeroecology
10. Significant impact factor boost for scientific journal Genome Research
11. Scientific information largely ignored when forming opinions about stem cell research

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)... University researchers Ron Falta and Larry Murdoc...on Agency grant to study the safe storage of carbo...low the earth,s surface. , With carbon dioxide e...the leading cause of global warming, geologic stor...atives for reducing emissions using current techno...
(Date:11/30/2009)...esearchers from LSU Health Sciences Center New Orl...er National Institute of Child Health and Human De..., Brigham and Women,s Hospital, and Harvard Medica...ing more than 5 servings of sugar- sweetened cola ... elevate the risk of developing diabetes during pr...
(Date:11/30/2009)...sion proteins are crucial for infection. Each bind...s, which stimulates the host cell to take up the p...a different function, for example the regulation o...ts have now been published in the current issue of... meat is one of the sources for Listeria infecti...
Breaking Biology News(10 mins):Sugary cola drinks linked for first time to higher risk of gestational diabetes 2Sugary cola drinks linked for first time to higher risk of gestational diabetes 3It takes 2 to infect 2UAB research finds childbearing increases chance of developing the metabolic syndrome 10040 1UAB research finds childbearing increases chance of developing the metabolic syndrome 10040 2From Kindergarten to College Go Back to School in Better Health 58069 1From Kindergarten to College Go Back to School in Better Health 58069 2From Kindergarten to College Go Back to School in Better Health 58069 3From Kindergarten to College Go Back to School in Better Health 58069 4Data Show Long Term Mechanical Integrity of MitraClip 28R 29 and Complete Healing Following Implantation of the Device for Mitral Valve Repair 58066 1Data Show Long Term Mechanical Integrity of MitraClip 28R 29 and Complete Healing Following Implantation of the Device for Mitral Valve Repair 58066 2Data Show Long Term Mechanical Integrity of MitraClip 28R 29 and Complete Healing Following Implantation of the Device for Mitral Valve Repair 58066 3
...he academic journal Mammal Review has uncovered th...vaquita. With a body less than 1.5 m long, the vaq...tacea consists of whales, dolphins and porpoises)....m2) and one of the smallest populations ( , The va...e Gulf of California (north of 30ยบ45,N and mainly ...
...s Hopkins, High Throughput Biology Center have inv... used to help identify otherwise elusive disease-c...ong believed to be "junk." , A variety of DNA micr...d the TIP-chip (transposable element insertion poi...ng genes have landed and disrupted normal gene fun...
...rected by Scripps Research Professor Benjamin Crav...issue of The Journal of Biological Chemistry. , Th... one previously suggested-for the biosynthesis of ...s), which include the endogenous cannabinoid ("end...e enzyme a/b hydrolase4 (Abh4) in areas such as th...
Other Biology News:Small, smaller, smallest -- The plight of the vaquita 2Small, smaller, smallest -- The plight of the vaquita 3Small, smaller, smallest -- The plight of the vaquita 4Taking 'chips' to the next level of gene hunting 2Taking 'chips' to the next level of gene hunting 3'Conversation stoppers' fight deadly bacterial infections 2
(Date:11/30/2009)... , CHANGCHUN, China and LOS ANGELES, Nov. 3...rmaceuticals, Inc. (OTC Bulletin Board: CYXN; ,Chi...eading manufacturer, distributor and,retailer of p...ced it has,completed preparation for distribution ... The Chinese government recently formalized the n...
(Date:11/30/2009)... , SEATTLE, Nov. 30 /PRNewswire-FirstCall/ -...TIC) announced today that its new class of platinu...s, demonstrated a stronger anti-tumor potency and ...based compounds as well as the ability to overcome...esults were presented in a paper titled "Novel Bis...
(Date:11/30/2009)... , AMSTERDAM, Novembe...,s,leading publisher of scientific, medical and te...ajor re-launch of Embase, its comprehensive biomed...records from more than 7,000,active, peer reviewed... role in the advancement of new biomedical,and pha...
(Date:11/27/2009)..., PARIS, November 27 /PRNewswire-FirstCall/ -...to market Oralair(R) in both adults and children,t...e first country where,Oralair(R) has been marketed...ir(R) is now registered in Austria, Belgium, Bulga...Germany, Greece, Hungary, Ireland, Italy,Latvia, ...
Breaking Biology Technology:China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 2China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 3New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 2New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 3Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 2Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 3STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 2STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 3
...provider of centralized ECG and eClinical technolo...cal, medical device, and related industries, annou...o of products and services on Booth #1253/1254 at ...in Berlin, Germany. ERT is also inviting attendees...e impact of technology and standards on drug deliv...
...orate partially absorbable mesh for use in the tre...d to improve healing and patient comfort , , SO...amp; Urology, a division of Ethicon, Inc., a Johns... GYNECARE PROLIFT+M(TM) Pelvic Floor Repair System...surgery to treat pelvic organ prolapse. GYNECARE P...
...arma Ltd., a,privately-held drug development compa...ed that it has begun a new Phase IIa clinical test... novel topical drug for,dermatology. The double-bl...ate the tolerability, pharmacokinetics, and effica...s with mild to moderate plaque psoriasis. The,subj...
Other Biology Technology:ERT to Showcase Its Clinical Trials Portfolio at DIA's 21st Euromeeting 2ERT to Showcase Its Clinical Trials Portfolio at DIA's 21st Euromeeting 3GYNECARE PROLIFT+M(TM) Pelvic Floor Repair System Launched in US for Use in Pelvic Organ Prolapse Surgery 2GYNECARE PROLIFT+M(TM) Pelvic Floor Repair System Launched in US for Use in Pelvic Organ Prolapse Surgery 3BioCis Pharma Starts Phase IIa Trial in Psoriasis 2
...s the most highly integrated comprehensive environ...ecular biology data management available on Mac OS...manage view analyze transform share and publicize ... one integrated analysis environment., ,Catal...
Rabbit Serum from BioVision
Chloramphenicol Acetyltransferase Fluorometric (BODIPY) Assay Kit, FAST CAT from Molecular Probes (Invitrogen)
Rabbit Anti-S-Adenosyl-Homocysteine Polyclonal Antibody, Unconjugated from AbD Serotec
Biology Products: